Skip to content Skip to footer
U.S. stocks finished Monday sharply lower, with the Nasdaq Composite falling 2.49%, the S&P 500 losing 1.92% and the Dow Jones Industrial Average declining 739.38 points. The markets realized losses across large-cap and small-cap shares, while the Cboe Volatility Index jumped 22.06%…
A volatile tape has produced an unexpectedly investable combination: major retailers are receiving fresh tariff refunds, mortgage rates have edged lower, and the debate around California’s proposed wealth tax underscores rather than erases Silicon Valley’s enduring economic gravity. For investors, the message…
U.S. stocks finished broadly higher on Thursday, August 13, as investors welcomed a benign producer-inflation report and maintained confidence in the large-cap technology and artificial-intelligence growth narrative. All four major U.S. equity benchmarks—the S&P 500, Dow Jones Industrial Average, Nasdaq Composite, and…
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) and Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX) offer investors two distinctly attractive versions of the same biotech proposition: value creation through disciplined execution. Jazz is deploying capital to deepen an established rare-epilepsy franchise, while Eupraxia is assembling the…